Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1158/2159-8290.CD-21-0210 http://scihub22266oqcxt.onion/10.1158/2159-8290.CD-21-0210 33811043!?!33811043       Cancer+Discov 2021 ; 11 (6): 1330-1335 Nephropedia Template TP {{tp|p=33811043|t=2021. Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic |pdf=|usr=}}{{33811043}} gab.com Text Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic JO: Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=33811043 #FOAvip Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months. Twit Text FOAVip Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic ????Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=33811043 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33811043 #FOAvip English Wikipedia <ref>{{Cite pmid|33811043}}</ref> Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic #MMPMID33811043 Labaki C; Peters S; Choueiri TK Cancer Discov 2021[Jun]; 11 (6): 1330-1335 PMID33811043show ga Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months. |Antineoplastic Agents/*therapeutic use[MESH] |COVID-19/*complications[MESH] |Clinical Decision-Making[MESH] |Evidence-Based Medicine[MESH] |Humans[MESH] |Neoplasms/*drug therapy/virology[MESH] |Pandemics[MESH]Treatment Decisions for Patients with Cancer during the COVID-19 Pande(epmc).pdf DeepDyve Pubget Overpricing